Influenza vaccination and anti‐neutrophil cytoplasmic antibody‐associated vasculitis

E-ISSN： 1440-1797|20|7|511-512

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.7, 2015-07, pp. : 511-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Outcome and Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Japan

Nephron Clin Pract, Vol. 115, Iss. 1, 2010-02 ,pp. : c21-c27

Karger

Access to resources Recommend Favorite

Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody‐associated vasculitis

NEPHROLOGY, Vol. 20, Iss. 5, 2015-05 ,pp. : 343-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab in the Treatment of Anti-Neutrophil Cytoplasm Antibody-Associated Vasculitis

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 243-249

Karger

Access to resources Recommend Favorite

Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3151-3159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Peripheral CD5+ B Cells in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 2, 2015-02 ,pp. : 535-544

John Wiley & Sons Inc

Access to resources Recommend Favorite